Page 7 - NewsletterVol2
P. 7

RECENT PER AREA







                  The key performance indicators for the evaluation of the effectiveness of the dissemination tools are
         WP2      systematically evaluated internally in WP2 and WP2 beneficiaries have initiated the interim evaluation
                  of Dissemination Strategy according to a main Milestone of the WP.



                  EVALUATION
         WP3      WP Leader: MoH HR, Croatia
                  The main  goal of WP3 is to ensure that the project is being implemented as planned, reaches its objectives
                  and produces high quality deliverables. In accordance with the specific objectives of the project, the
                  External Advisory Board composed by recognized experts has been established and has provided
                  expertise in the evaluation of specific scientific and/or expert issues of project events and outputs.
                  One  deliverable  (D3.1  -  Final  Evaluation  Plan)  has  been  produced.  This  document  sets  out  an
                  evaluation methodology to be implemented during the GAPP Joint Action lifetime, starting May 2018.


                   External advisory board                      Info

                                       Johanna C. Wiersum-      1) Sanquin Blood Bank
                   BLOOD               Osselton, MD, PhD        2) TRIP National hemovigilance and biovigilance
                                                                office, Leiden, The Netherlands
                                       Prof. Johan Guns, MSc.   UZ Brussel (University Hospital Vrije Universiteit
                   TISSUES                                      Brussel-VUB, Brussels, Belgium

                                       Ineke Slaper Cortenbach,   Slaper-Cortenbach, biomedical consultancy, De Bilt,
                   HSC
                                       PhD                      Netherlands
                   MAR                 Kelly Tilleman, MD, PhD  Ghent University Hospital, Ghent, Belgium
                                       Ines Ushiro Lumb, MD,    1) National Health Service Blood and Transplant
                   TTD testing
                                       MSc, FRCPath             2) Public Health England, London, UK
                                       Veroniek Saegeman, MD,  1) AZ Nikolaas, Sint-Niklaas
                   MICROBIOLOGY
                                       PhD                      2) UZ Leuven, Leuven, Belgium
                   CLINICAL            Andrijana Tivadar,       Slovensko farmacevtsko društvo (SFD) - Slovenian
                   TRIALS              MPharm, PhD              Pharmaceutical Society, Ljubljana, Slovenia

                  Five GAPP events were evaluated and analyzed, one deliverable was evaluated with the contribution
                  of External Advisory Board. More than 15 surveys have been made and distributed via SurveyMonkey
                  among the project collaborating and associated beneficiaries with the aim of assuring the highest
                  possible quality of GAPP JA implementation.


                  INTEGRATION IN NATIONAL POLICIES AND SUSTAINABILITY
         WP4      WP Coleaders: RNDVCSH, Romania and ISS-CNT-CNS, Italy
                  This WP aims to set up a plan to describe the potential of GAPP results for integration in policies (at
                  national, regional or local levels) and to ensure the sustainability of the JA activities at national or on
                  the local or regional level.


        This brochure is part of the joint action ‘785269/GAPP’ which has received funding from the European Union’s   GAPP - Newsletter2   7
        Health Programme (2014-2020)
   2   3   4   5   6   7   8   9   10   11   12